ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 56,494,277
- Share change
- +847,366
- Total reported value
- $112,422,732
- Put/Call ratio
- 185%
- Price per share
- $1.99
- Number of holders
- 82
- Value change
- -$3,041,138
- Number of buys
- 45
- Number of sells
- 26
Quarterly Holders Quick Answers
What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP H0036K147:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
12%
|
15,669,217
|
$49,358,034 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
7.5%
|
9,636,237
|
$30,354,147 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.5%
|
4,533,801
|
$14,281,473 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.4%
|
4,399,134
|
$13,857,274 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.4%
|
3,040,794
|
$9,578,500 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
2,497,940
|
$7,868,511 | — | 30 Sep 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,795,080
|
$5,654,502 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,688,594
|
$5,319,071 | — | 30 Sep 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.1%
|
1,444,516
|
$4,550,225 | — | 30 Sep 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.91%
|
1,163,461
|
$3,664,902 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.86%
|
1,106,011
|
$3,483,935 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
953,171
|
$3,002,487 | — | 30 Sep 2024 | |
| Vantage Consulting Group Inc |
13F
|
Company |
0.66%
|
850,737
|
$2,679,822 | — | 30 Sep 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
733,568
|
$2,310,739 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.55%
|
712,401
|
$2,244,063 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.42%
|
539,359
|
$1,698,981 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
481,037
|
$1,515,267 | — | 30 Sep 2024 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.32%
|
410,888
|
$1,294,297 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.22%
|
284,243
|
$895,365 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
245,253
|
$772,547 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.16%
|
205,036
|
$645,863 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.16%
|
204,081
|
$642,855 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
194,258
|
$611,913 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.13%
|
168,557
|
$530,955 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
162,243
|
$511,065 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
129,058
|
$406,533 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
127,739
|
$402,377 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.09%
|
115,073
|
$362,480 | — | 30 Sep 2024 | |
| Florida Trust Wealth Management Co |
13F
|
Company |
0.09%
|
113,000
|
$355,950 | — | 30 Sep 2024 | |
| Wilmington Savings Fund Society, FSB |
13F
|
Company |
0.08%
|
100,000
|
$315,000 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
95,189
|
$299,839 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.06%
|
78,813
|
$248,261 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
75,392
|
$237,485 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
58,902
|
$185,541 | — | 30 Sep 2024 | |
| Magnetar Financial LLC |
13F
|
Company |
0.04%
|
55,762
|
$175,650 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
53,126
|
$167,347 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.04%
|
53,042
|
$167,084 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
43,481
|
$136,965 | — | 30 Sep 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.03%
|
43,089
|
$135,730 | — | 30 Sep 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
40,413
|
$127,000 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
39,845
|
$125,511 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
39,775
|
$125,292 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
38,274
|
$120,563 | — | 30 Sep 2024 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
36,214
|
$114,074 | — | 30 Sep 2024 | |
| DLK Investment Management, LLC |
13F
|
Company |
0.03%
|
33,155
|
$104,438 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
32,669
|
$102,907 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
29,998
|
$94,494 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
29,276
|
$92,219 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
28,831
|
$91,000 | — | 30 Sep 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
26,657
|
$84,000 | — | 30 Sep 2024 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q4 2024
As of 31 Dec 2024,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,494,277 shares.
The largest 10 holders included
Redmile Group, LLC, Prosight Management, LP, ORBIMED ADVISORS LLC, BlackRock, Inc., MORGAN STANLEY, Woodline Partners LP, GOLDMAN SACHS GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, BANK OF AMERICA CORP /DE/, and STATE STREET CORP.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
76
Q4 2024 holders
82
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.